Assessment of Helicobacter pylori clarithromycin resistance mutations in archival gastric biopsy samples

Swiss Medical Weekly

Volumn 135, Issue 21-22, 2005, Pages 327-332

  Soltermann, Alex ^a   Perren, Aurel ^a   Schmid, Sonja ^a   Eigenmann, Franz ^b   Güller, Rudolf ^b   Weber, Kurt E ^b   Meier, Jürg ^b   Eichenberger, Peter ^b   Komminoth, Paul ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Kantonsspital Baden   (Switzerland)

Author keywords

23s rRNA; Clarithromycin; Gastric biopsy; Helicobacter; Histology; Resistance

Indexed keywords

CLARITHROMYCIN; RIBOSOME RNA;

50S RIBOSOMAL SUBUNIT; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ERADICATION THERAPY; GENE MUTATION; GENE SEQUENCE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; HYBRIDIZATION; NONHUMAN; PERSISTENT INFECTION; POINT MUTATION; POLYMERASE CHAIN REACTION; RIBOSOME SUBUNIT; STOMACH BIOPSY; TECHNIQUE; TREATMENT OUTCOME;

EID: 21744432170     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Böttger EC, Kern P. Molekulare Mechanismen und klinische Aspekte der Resistenz. In: Ganten D, Ruckpaul K, editors. Handbuch der Molekularen Medizin: Immunsystem und Infektiologie. Berlin, Heidelberg: Springer Verlag; 1999. p. 386-411.
2. Hulten K, Cars O, Hjelm E, Engstrand L. In-vitro activity of azithromycin against intracellular Helicobacter pylori. J Antimicrob Chemother 1996;37:483-9.
3. Schlunzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, et al. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 2001; 413:814-21.
4. Taylor DE, Ge Z, Purych D, Lo T, Hiratsuka K. Cloning and sequence analysis of two copiesofa23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob Agents Chemother 1997;41:2621-8.
5. Maeda S, Yoshida H, Ogura K, Kanai F, Shiratori Y, Omata M. Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. Gut 1998;43:317-21.
6. van Doorn LJ, Glupczynski Y, Kusters JG, Megraud F, Midolo P, Maggi-Solca N, et al. Accurate prediction of macrolide resistance in Helicobacter pylori by a PCR line probe assay for detection of mutations in the 23S rRNA gene: multicenter validation study. Antimicrob Agents Chemother 2001;45:1500-4.
7. Komminoth P, Roth J, Muletta-Feurer S, Saremaslani P, Seelentag WK, Heitz PU. RET proto-oncogene point mutations in sporadic neuroendocrine tumors. J Clin Endocrinol Metab 1996;81:2041-6.
8. Komminoth P, Kunz E, Hiort O, Schroder S, Matias-Guiu X, Christiansen G, et al. Detection of RET proto-oncogene point mutations in paraffin-embedded pheochromocytoma specimens by nonradioactive single-strand conformation polymorphism analysis and direct sequencing. Am J Pathol 1994;145: 922-9.
9. Stone GG, Shortridge D, Flamm RK, Versalovic J, Beyer J, Idler K, et al. Identification of a 23S rRNA gene mutation in clarithromycin-resistant Helicobacter pylori. Helicobacter 1996;1: 227-8.
10. Debets-Ossenkopp YJ, Herscheid AJ, Pot RG, Kuipers EJ, Kusters JG, Vandenbroucke-Grauls CM. Prevalence of Helicobacter pylori resistance to metronidazole, darithromycin, amoxycillin, tetracycline and trovafloxacin in The Netherlands. J Antimicrob Chemother 1999;43:511-5.
11. Lehmann FS, Drewe J, Terracciano L, Beglinger C. Effect of ornidazole and clarithromycin resistance on eradication of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther 2000;14:305-9.
12. Matsumura M, Hikiba Y, Ogura K, Togo G, Tsukuda I, Ushikawa K, et al. Rapid detection of mutations in the 23S rRNA gene of Helicobacter pylori that confers resistance to clarithromycin treatment to the bacterium. J Clin Microbiol 2001;39:691-5.
13. Fontana C, Favaro M, Minelli S, Criscuolo AA, Pietroiusti A, Galante A, et al. New site of modification of 23S rRNA associated with clarithromycin resistance of Helicobacter pylori clinical isolates. Antimicrob Agents Chemother 2002;46:3765-9.
14. Hao Q, Li Y, Zhang ZJ, Liu Y, Gao H. New mutation points in 23S rRNA gene associated with Helicobacter pylori resistance to clarithromycin in northeast China. World J Gastroenterol 2004;10:1075-7.
15. van der Ende A, van Doom LJ, Rooijakkers S, Feller M, Tytgat GN, Dankert J. Clarithromycin-susceptible and -resistant Helicobacter pylori isolates with identical randomly amplified polymorphic DNA-PCR genotypes cultured from single gastric biopsy specimens prior to antibiotic therapy. J Clin Microbiol 2001;39:2648-51.
16. Fantry GT, Zheng QX, Damin PE, Rosenstein AH, James SP. Mixed infection with cagA-positive and cagA-negative strains of Helicobacter pylori. Helicobacter 1996;1:98-106.
17. Marais A, Monteiro L, Occhialini A, Pina M, Lamouliatte H, Megraud F. Direct detection of Helicobacter pylori resistance to niacrolides by a polymerase chain reaction/DNA enzyme immunoassay in gastric biopsy specimens. Gut 1999;44:463-7.
18. Björkholm B, Sjolund M, Falk PG, Berg OG, Engstrand L, Andersson DI. Mutation frequency and biological cost of antibiotic resistance in Helicobacter pylori. Proc Natl Acad Sci U S A 2001;98:14607-12.
19. Zambon CF, Navaglia F, Basso D, Rugge M, Plebani M. Helicobacter pylori babA2, cagA, and si vacAgenes work synergistically in causing intestinal metaplasia. J Clin Pathol 2003;56:287-91.
20. Kim JJ, Kim JG, Kwon DH. Mixed-infection of antibiotic susceptible and resistant Helicobacter pylori isolates in a single patient and underestimation of antimicrobial susceptibility testing. Helicobacter 2003;8:202-6.